- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06237439
Sharing HaRT in New Expanses (SHiNE)
January 23, 2024 updated by: Catherine Carlson, University of Alabama, Tuscaloosa
Sharing HaRT in New Expanses: Evaluating the Move With HaRT Intervention on Improving Mental Health of Human Trafficking Survivors
The goal of this parallel cluster randomized control (CRT) trial is to evaluate a group-based mind-body intervention (Move with HaRT) in survivors of human trafficking. The main study aims are:
- Determine effectiveness of the Move with HaRT intervention on PTSD, depression, and anxiety symptoms among survivors of human trafficking in Uganda
- Explore participant characteristics (e.g., age, trafficking history, food security) that may moderate the intervention effectiveness.
- Understand potential barriers and facilitators to future implementation and scale-up.
Participants will complete:
- Complete three surveys (baseline, endline, and 3 month follow-up)
- Participate in either Services as Usual or Move with HaRT groups
- Qualitative in-depth interviews
Researchers will compare Move with HaRT with Services as Usual to see effects on mental health symptoms.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
Despite significant mental health challenges experienced by human trafficking survivors, a lack of research on effective interventions exists.
The proposed parallel cluster randomized control trial aims to evaluate the mental health impact of Move with HaRT with human trafficking survivors in Uganda.
Move with HaRT is a group-based intervention facilitated by paraprofessionals that includes breathwork, yoga poses, meditation, and discussions.
The proposed study will use a parallel cluster randomized control (CRT) trial with 302 survivors randomized in groups to either Move with HaRT or Services as Usual.
The main study aims are: 1) Determine effectiveness of the Move with HaRT intervention on PTSD, depression, and anxiety symptoms among survivors of human trafficking in Uganda; 2) Explore participant characteristics (e.g., age, trafficking history, food security) that may moderate the intervention effectiveness; 3) Understand potential barriers and facilitators to future implementation and scale-up.
Surveys at baseline, endline, and 3-month follow-up assess mental health outcomes, as well as secondary outcomes on physical and social wellbeing.
Qualitative research will inform barriers and facilitators to future implementation and scale-up.
Results of this study have the potential to inform protection services in Uganda and beyond.
Study Type
Interventional
Enrollment (Estimated)
302
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Gloria E Ayesiga, MA
- Phone Number: +256759252676
- Email: gayesiga@poverty-action.org
Study Locations
-
-
-
Kampala, Uganda
- Recruiting
- Innovations for Poverty Action, Uganda
-
Contact:
- Gloria E Ayesiga, MA
- Phone Number: +256759252676
- Email: gayesiga@poverty-action.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- identify as female;
- history of forced labor or sex trafficking;
- aged 14 and above;
Exclusion Criteria:
- physically unable to perform basic day-to-day activities without assistance
- does not provide consent (or assent if a minor)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Move with HaRT
Move with HaRT is a 12-session, weekly, manualized mental health intervention led by trained paraprofessionals.
It is delivered in groups of 8-12 individuals and includes breathwork, yoga poses, guided meditations, and discussions aligned with weekly themes.
Group discussions include topics such as noticing how we feel in our bodies, recognizing and allowing all emotions, practicing self-acceptance, and developing deeper connections with others with whom we feel safe.
|
Move with HaRT is a group-based, manualized mind-body intervention.
|
|
Active Comparator: Services as Usual
Services as usual are ongoing activities provided by anti-trafficking agencies that include basic counseling, vocational training, games and entertainment (e.g., movies and social activities).
|
Move with HaRT is a group-based, manualized mind-body intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire (PHQ-9)
Time Frame: Past two weeks
|
Severity of depressive symptoms
|
Past two weeks
|
|
PTSD Checklist (PCL-5)
Time Frame: Past one month
|
Severity of post-traumatic stress symptoms
|
Past one month
|
|
GAD-7
Time Frame: Past one month
|
Severity of generalized anxiety symptoms
|
Past one month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brief Pain Inventory (Short Form)
Time Frame: 24 hours
|
Severity of pain
|
24 hours
|
|
Women's Health Initiative Insomnia Rating Scale (WHIIRS)
Time Frame: Past four weeks
|
Severity of insomnia symptoms
|
Past four weeks
|
|
Multidimensional Scale of Perceived Social Support (MSPSS)
Time Frame: Past three months
|
Degree of perceived social support
|
Past three months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Catherine E Carlson, University of Alabama at Birmingham
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 21, 2023
Primary Completion (Estimated)
February 1, 2025
Study Completion (Estimated)
May 1, 2025
Study Registration Dates
First Submitted
January 23, 2024
First Submitted That Met QC Criteria
January 23, 2024
First Posted (Estimated)
February 1, 2024
Study Record Updates
Last Update Posted (Estimated)
February 1, 2024
Last Update Submitted That Met QC Criteria
January 23, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-02-6355
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Symptoms
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
-
University of California, San DiegoRecruitingDepressive Disorder | Depression | Depressive Symptoms | Major Depressive Disorder | Treatment Resistant DepressionUnited States
-
Julia EderNot yet recruitingDepressive Disorder | Depression | Depressive Symptoms | Major Depressive Disorder | Depressive EpisodeGermany
-
The Royal Ottawa Mental Health CentreNot yet recruitingDepression | Major Depressive Disorder (MDD) | Depressive Episode | Depression - Major Depressive DisorderCanada
-
Finnish Institute for Health and WelfareUniversity of Helsinki; Tampere University; University of Eastern Finland; Strategic...RecruitingMajor Depressive Disorder | Depressive Symptoms Mild to Moderate in SeverityFinland
-
Uppsala UniversityRecruitingPostpartum | Attachment | Depression - Major Depressive DisorderSweden
-
Dr. Nazanin AlaviCompletedDepression | Depressive Symptoms | Major Depressive DisorderCanada
-
Linkoeping UniversityCompletedMajor Depressive DisorderSweden
-
The University of Texas Health Science Center at...TerminatedDepression | Major Depressive DisorderUnited States
-
Santa Casa Medical SchoolFaculdade de Ciências Médicas da Santa Casa de São PauloUnknownDepressive SymptomsBrazil
Clinical Trials on Move with HaRT
-
Boston Medical CenterCompletedSexual Behavior
-
Massachusetts General HospitalActive, not recruitingMiddle AgedUnited States
-
Arkansas Children's Hospital Research InstituteRecruiting
-
University of PittsburghRecruitingAlzheimers Disease Related DementiasUnited States
-
VA Office of Research and DevelopmentCompleted
-
VA Office of Research and DevelopmentThe American Legion Department of Wisconsin; Veterans Of Foreign Wars Of The... and other collaboratorsCompletedHypertension | Obesity | Diabetes Mellitus | OverweightUnited States
-
Hospital de Clinicas de Porto AlegreUniversity of Sao Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo; Centro de Inovação em Saúde Mental (CISM) and other collaboratorsRecruitingAttention Deficit Hyperactivity DisorderBrazil
-
VA Office of Research and DevelopmentCompletedPTSD | Obesity | OverweightUnited States
-
Brandon HathornBaylor Heart and Vascular Institute Cardiovascular Research Review CommitteeCompletedCoronary Artery Disease | Valve Disease, Heart
-
Superior UniversityActive, not recruitingAccommodative InsufficiencyPakistan